Heidelberg Engineering

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Heidelberg Engineering sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials none currently recruiting 11 completed top decile by trial count

Heidelberg Engineering: 16 sponsored US clinical trials, none currently recruiting.

Heidelberg Engineering sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 11 completed. The most-studied condition in this pipeline is IOL, with 1 trials.

Top-decile sponsor footprint

Heidelberg Engineering ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 22/100

11 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

16 total, page 1 of 1

ACTIVE NOT RECRUITING

Heidelberg Engineering ANTERION Software Comparison Study

NCT06657716

TERMINATED

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

NCT06397976

COMPLETED

The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study

NCT05051813

COMPLETED

Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements

NCT04961398

COMPLETED

Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position

NCT04661124

COMPLETED

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

NCT04604002

COMPLETED

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

NCT04130490

COMPLETED

The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study

NCT04083742

COMPLETED

The Heidelberg Engineering ANTERION Imaging Agreement Study

NCT04068818

COMPLETED

The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study

NCT03903588

COMPLETED

The Heidelberg Engineering BI US Evaluation Study

NCT03578302

TERMINATED

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

NCT03530449

COMPLETED

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

NCT03279939

TERMINATED

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)

NCT02785029

TERMINATED

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

NCT02785042

COMPLETED

Optical Coherence Tomography (OCT) Normative Data Collection Study

NCT02014688

How the Heidelberg Engineering archive is shaped

16 indexed studies, none listed as recruiting (0% open); 11 completed (69%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: IOL (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Heidelberg Engineering: archived-pipeline peers nationwide

Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Heidelberg Engineering sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%5%10%15% Total trials Recruiting share Heidelberg EngineeringAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Heidelberg Engineering sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Heidelberg Engineering sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Heidelberg Engineering page

16 registered trials is a research-attention snapshot, not an endorsement of Heidelberg Engineering or any single study.

  • None of Heidelberg Engineering's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • IOL is the condition Heidelberg Engineering studies most, compare against other sponsors active in the same condition before evaluating a specific study. See IOL trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Heidelberg Engineering pipeline card: 16 registered trials from official public datasets.Report a data error.